Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latino Semaglutide Study
NCT05087342Phase 3Completed
- Sponsor
- Loma Linda University
- Start
- Dec 2022
- Primary completion
- May 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of semaglutide in obesity, sponsored by Loma Linda University. Started Dec 2022; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05087342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05087342.